Exscientia
EXAI · NASDAQ
Price unavailable right now.
No price history for this range.
Who owns EXAI
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 27.4% of EXAI’s shares.
- Hopkins (Andrew)14.8%
- Evotech Capital, S.A.10.9%
- Bill & Melinda Gates Foundation1.2%
- CSS, LLC0.1%
- Next 6 largest institutions0.4%
- All other shareholders72.6%
| Holder | Shares | % of shares |
|---|---|---|
| Hopkins (Andrew) | 19.12M | 14.80% |
| Evotech Capital, S.A. | 14.04M | 10.86% |
| Bill & Melinda Gates Foundation | 1.59M | 1.23% |
| CSS, LLC | 126.78K | 0.10% |
| Crain (Elizabeth A) | 115.17K | 0.09% |
| Baillie Gifford Overseas Ltd. | 113.61K | 0.09% |
| Russell Investments Trust Company | 98.94K | 0.08% |
| Taylor (Ben R) | 80.05K | 0.06% |
| Deka Investment GmbH | 80.00K | 0.06% |
| Deka Vermögensmanagement GmbH | 80.00K | 0.06% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Platinum International Health Sciences Fund | 1.46M | 1.13% |
| DekaLux-BioTech | 80.00K | 0.06% |
| Nissay Global Digital Healthcare Equity Fund (Annual Settlement, Non Hed | 74.64K | 0.06% |
| AB All Market Total Return Portfolio | 8.60K | 0.01% |
| China Universal Nasdaq Biotechnology ETF (QDII) | 5.75K | 0.00% |
Short interest
Settled Nov 15, 2024
- Shares short
- 3.04M
- Days to cover
- 3.22
- % of shares outstanding
- 2.35%
- Average daily volume
- 944.19K
- Change since last report
- +8.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.